Instrument Inactif

Communiqués Sylogist Ltd. Other OTC

Actions

SYZLF

CA87132P1027

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sylogist Announces Addition of Experienced SaaS Executive to its Board of Directors and Annual General & Special Meeting Results	13/06	AQ
Sylogist Declares Quarterly Dividend (Ex-Dividend Date Correction)	11/05	NE
SYLOGIST Reports First Quarter 2024 Results	09/05	AQ
United Way of Metropolitan Dallas Chooses SylogistMission	08/05	AQ
Sylogist to Host First Quarter 2024 Earnings Conference Call	24/04	NE
Sylogist Reports Record Fourth Quarter and Full Year 2023 Results	14/03	AQ
Sylogist to Host Fourth Quarter 2023 Earnings Conference Call	26/02	NE
Sylogist Acquires Innovative Time Tracking & Scheduling SaaS Solution for its Gov, Ed and Mission Platforms	23/02	AQ
Sylogist Declares Quarterly Dividend	16/02	AQ
Sylogist Ltd. Announces Two New Directors	07/02	AQ
SYLOGIST Reports Strong Third Quarter 2023 Results	09/11	NE
Sylogist to Host Third Quarter 2023 Earnings Conference Call	01/11	NE
Sylogist Ltd. Announces Changes to Board of Directors	28/08/23	AQ
Sylogist Reports 21% Y/Y Organic Growth and 26% Adjusted EBITDA Margin for Q2 ‘23	10/08/23	AQ
Sylogist to Discuss Performance for Q2 2023	03/08/23	AQ
Sylogist Annual General and Special Meeting Results and Board Committee Appointments	28/06/23	AQ
Sylogist and PenderFund Capital Management Enter Into Nomination Agreement	21/06/23	AQ
Sylogist to Host Investor Day, Engages LodeRock Advisors	19/05/23	AQ
Sylogist to Participate in the CIBC Technology & Innovation Conference	17/05/23	AQ
Sylogist Continues Acceleration with 21% Organic Growth and Record Quarterly Revenue, Releases Quarterly Financial Results	11/05/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Sylogist Ltd. Other OTC

Actions

SYZLF

CA87132P1027

Communiqués

Filtres